SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 76.07+0.9%Nov 12 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ian@SI who wrote (833)2/17/2005 3:31:55 PM
From: scaram(o)uche  Read Replies (2) of 3722
 
>> What makes this company compelling? <<

Nothing, absolutely nothing. Don't like the CEO, and I have zero respect for the CEO of the company that they purchased. Add extreme, well-informed pumping at yahoo as Cyclis insiders were bailing, and the company doesn't give you the warm and fuzzies.

But worth a bet or watching? beta-lapachone...... go to PubMed.... it's an exciting molecule to have in human testing. Clean balance sheet, low burn, combo therapy trial enrolling, price:book of two.

Clearly, Cyclis insiders feel that they really stuck ARQL with a loser, or they're deeply in debt, or (and this is where the "clearly" part is justified) sumthin.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext